NO20030139L - Farmasöytiske preparater inneholdende DDS forbindelser - Google Patents

Farmasöytiske preparater inneholdende DDS forbindelser

Info

Publication number
NO20030139L
NO20030139L NO20030139A NO20030139A NO20030139L NO 20030139 L NO20030139 L NO 20030139L NO 20030139 A NO20030139 A NO 20030139A NO 20030139 A NO20030139 A NO 20030139A NO 20030139 L NO20030139 L NO 20030139L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations containing
dds compounds
containing dds
compounds
Prior art date
Application number
NO20030139A
Other languages
English (en)
Other versions
NO20030139D0 (no
Inventor
Masayuki Takahashi
Shuichi Sugie
Masahito Takeuchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20030139D0 publication Critical patent/NO20030139D0/no
Publication of NO20030139L publication Critical patent/NO20030139L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030139A 2000-07-13 2003-01-10 Farmasöytiske preparater inneholdende DDS forbindelser NO20030139L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000213083 2000-07-13
PCT/JP2001/006020 WO2002005855A1 (fr) 2000-07-13 2001-07-11 Compositions pharmaceutiques contenant des composes dds

Publications (2)

Publication Number Publication Date
NO20030139D0 NO20030139D0 (no) 2003-01-10
NO20030139L true NO20030139L (no) 2003-03-13

Family

ID=18708899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030139A NO20030139L (no) 2000-07-13 2003-01-10 Farmasöytiske preparater inneholdende DDS forbindelser

Country Status (12)

Country Link
US (1) US6815435B2 (no)
EP (1) EP1308171A1 (no)
KR (1) KR20030023697A (no)
CN (1) CN1556712A (no)
AR (1) AR031714A1 (no)
AU (1) AU2001271037A1 (no)
BR (1) BR0112417A (no)
CA (1) CA2415922A1 (no)
MX (1) MXPA03000387A (no)
NO (1) NO20030139L (no)
RU (1) RU2003100532A (no)
WO (1) WO2002005855A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001267831A1 (en) * 2000-06-29 2002-01-08 Daiichi Pharmaceutical Co., Ltd. DDS compound and process for the preparation thereof
TWI320713B (no) 2001-06-01 2010-02-21 Neochemir Inc
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
EP1570851A4 (en) * 2002-12-10 2007-07-25 Masaya Tanaka SKIN SUBSTANCE FOR EXTERNAL USE AND ANTI-PRURIENT AGENT FOR EXTERNAL USE AND REDUCING INSTRUMENT FOR WRINKLES USING THE SAME
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
EP2552418B1 (en) 2010-03-29 2017-08-09 Ferring B.V. A fast dissolving pharmaceutical composition
AU2013263795B2 (en) * 2010-03-29 2015-09-17 Ferring B.V. A fast dissolving pharmaceutical composition
JP6174585B2 (ja) 2011-09-16 2017-08-02 フェリング ベスローテン フェンノートシャップ 速溶性医薬組成物
KR102540419B1 (ko) 2012-10-11 2023-06-05 다이이찌 산쿄 가부시키가이샤 글리신아미드 화합물의 제조 방법
US9872924B2 (en) 2012-10-19 2018-01-23 Daiichi Sankyo Company, Limited Antibody-drug conjugate produced by binding through linker having hydrophilic structure
KR101941758B1 (ko) 2013-12-25 2019-01-24 다이이찌 산쿄 가부시키가이샤 항 trop2 항체-약물 컨쥬게이트
EP3466976B1 (en) 2014-01-31 2021-09-08 Daiichi Sankyo Company, Limited Anti-her2 antibody-drug conjugate
CN111228511B (zh) 2014-04-10 2024-06-18 第一三共株式会社 抗her3抗体-药物偶联物
US11185594B2 (en) 2014-04-10 2021-11-30 Daiichi Sankyo Company, Limited (Anti-HER2 antibody)-drug conjugate
CN113304278A (zh) 2014-12-26 2021-08-27 日本化药株式会社 喜树碱类高分子衍生物的药物制剂
CA2990572C (en) 2015-06-29 2022-07-26 Daiichi Sankyo Company, Limited Method for selectively manufacturing antibody-drug conjugate
JP6735759B2 (ja) 2015-09-03 2020-08-05 日本化薬株式会社 カンプトテシン類高分子誘導体を含有する医薬組成物
AU2017226131A1 (en) 2016-03-01 2018-10-04 Nippon Kayaku Kabushiki Kaisha Pharmaceutical preparation containing camptothecin-based polymeric derivative
US11273155B2 (en) 2016-12-12 2022-03-15 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and immune checkpoint inhibitor
KR102537651B1 (ko) 2017-01-17 2023-05-26 다이이찌 산쿄 가부시키가이샤 항 gpr20 항체 및 항 gpr20 항체-약물 콘쥬게이트
TWI794230B (zh) 2017-05-15 2023-03-01 日商第一三共股份有限公司 抗cdh6抗體及抗cdh6抗體-藥物結合物、以及其製造方法
JP7366745B2 (ja) 2017-08-31 2023-10-23 第一三共株式会社 抗体-薬物コンジュゲートの改良製造方法
CN117865839A (zh) 2017-08-31 2024-04-12 第一三共株式会社 制备抗体-药物缀合物的新方法
RS64379B1 (sr) 2018-05-18 2023-08-31 Glycotope Gmbh Anti-muc1 antitelo
KR20220051332A (ko) 2019-07-10 2022-04-26 싸이브렉사 3, 인크. 치료제로서의 미세소관 표적화제의 펩티드 접합체
JP2022541749A (ja) 2019-07-10 2022-09-27 サイブレクサ 2,インコーポレイテッド 治療薬としての細胞毒素のペプチドコンジュゲート

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
EP0857484A4 (en) * 1995-09-13 2000-12-06 Nippon Shinyaku Co Ltd PGE1- FREEZING DRIED PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
PL328309A1 (en) * 1996-02-19 1999-01-18 Nycomed Imaging As Thermally stabilised contrast medium
WO1997035135A1 (en) * 1996-03-19 1997-09-25 The Morgan Crucible Company Plc. A conduit
JPH10212241A (ja) * 1996-05-27 1998-08-11 Sumitomo Pharmaceut Co Ltd Bdnfを安定に含有する製剤
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex
CA2345612A1 (en) * 1998-09-29 2000-04-06 Masao Nagao Anti-fungal composition

Also Published As

Publication number Publication date
CA2415922A1 (en) 2002-01-24
MXPA03000387A (es) 2003-09-22
WO2002005855A1 (fr) 2002-01-24
CN1556712A (zh) 2004-12-22
BR0112417A (pt) 2003-07-01
US6815435B2 (en) 2004-11-09
RU2003100532A (ru) 2004-07-20
AR031714A1 (es) 2003-10-01
NO20030139D0 (no) 2003-01-10
KR20030023697A (ko) 2003-03-19
US20030148931A1 (en) 2003-08-07
EP1308171A1 (en) 2003-05-07
AU2001271037A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
NO20030139L (no) Farmasöytiske preparater inneholdende DDS forbindelser
NO20071303L (no) Farmasoytiske preparater
NO20033556D0 (no) Farmasöytiske preparater
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
ITTO20010008A0 (it) Formulazione farmaceutica
EE200200038A (et) Konservitud farmatseutilised preparaadid
NO20020464L (no) Flerkomponents farmasöytisk doseringsform
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
NO992339D0 (no) Farmas°ytiske formuleringer
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
MXPA03001425A (es) Compuestos farmaceuticos.
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20026013L (no) Medisinske preparater inneholdende propenonderivater
NO20014926D0 (no) Farmasöytiske forbindelser
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
DE69926012D1 (de) Arzneizubereitungen
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
EE200100697A (et) Farmatseutiline kompleks
AR025867A1 (es) Formulacion portasdora farmaceutica
DE69906934D1 (de) Arzneizubereitungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application